Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Yonsei University
University of Nebraska
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Mayo Clinic
University of Arizona
Ohio State University Comprehensive Cancer Center
Yale University
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Hoag Memorial Hospital Presbyterian
Heidelberg University
Ann & Robert H Lurie Children's Hospital of Chicago